In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of TrueBlue Inc (NYSE: TBI) closed at $4.62 in the last session, up 0.87% from day before closing price of $4.58. In other words, the price has increased by $0.87 from its previous closing price. On the day, 72483.0 shares were traded. TBI stock price reached its highest trading level at $4.64 during the session, while it also had its lowest trading level at $4.56.
Ratios:
We take a closer look at TBI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.01 and its Current Ratio is at 2.01. In the meantime, Its Debt-to-Equity ratio is 0.42 whereas as Long-Term Debt/Eq ratio is at 0.38.
Upgrades & Downgrades
In the most recent recommendation for the company, BMO Capital Markets on May 22, 2023, Upgraded its rating to Outperform and sets its target price to $20 from $18 previously.
On May 26, 2022, BMO Capital Markets Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $36 to $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 12 ’25 when Schweihs Carl bought 2,500 shares for $5.25 per share. The transaction valued at 13,125 led to the insider holds 169,051 shares of the business.
Owen Taryn R bought 12,735 shares of TBI for $75,646 on Feb 26 ’25. The CEO and President now owns 414,932 shares after completing the transaction at $5.94 per share. On Feb 24 ’25, another insider, Schweihs Carl, who serves as the EVP and CFO of the company, bought 10,000 shares for $6.25 each. As a result, the insider paid 62,500 and bolstered with 166,551 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TBI now has a Market Capitalization of 138320336 and an Enterprise Value of 244843344. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.09 while its Price-to-Book (P/B) ratio in mrq is 0.45. Its current Enterprise Value per Revenue stands at 0.155 whereas that against EBITDA is -30.728.
Stock Price History:
The Beta on a monthly basis for TBI is 1.47, which has changed by -0.43941247 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, TBI has reached a high of $8.56, while it has fallen to a 52-week low of $3.45. The 50-Day Moving Average of the stock is -8.22%, while the 200-Day Moving Average is calculated to be -18.08%.
Shares Statistics:
According to the various share statistics, TBI traded on average about 232.48K shares per day over the past 3-months and 266260 shares per day over the past 10 days. A total of 29.92M shares are outstanding, with a floating share count of 28.64M. Insiders hold about 4.34% of the company’s shares, while institutions hold 92.84% stake in the company. Shares short for TBI as of 1764288000 were 1317740 with a Short Ratio of 5.27, compared to 1761868800 on 1167261. Therefore, it implies a Short% of Shares Outstanding of 1317740 and a Short% of Float of 5.1799998.
Earnings Estimates
The firm’s stock currently is rated by 3.0 analysts. The consensus estimate for the next quarter is -$0.1, with high estimates of $0.03 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.47 and -$0.55 for the fiscal current year, implying an average EPS of -$0.51. EPS for the following year is $0.26, with 3.0 analysts recommending between $0.49 and -$0.04.
Revenue Estimates
According to 2 analysts,. The current quarter’s revenue is expected to be $413.31M. It ranges from a high estimate of $413.36M to a low estimate of $413.26M. As of. The current estimate, TrueBlue Inc’s year-ago sales were $385.95MFor the next quarter, 2 analysts are estimating revenue of $384.99M. There is a high estimate of $388.7M for the next quarter, whereas the lowest estimate is $381.27M.
A total of 2 analysts have provided revenue estimates for TBI’s current fiscal year. The highest revenue estimate was $1.61B, while the lowest revenue estimate was $1.59B, resulting in an average revenue estimate of $1.6B. In the same quarter a year ago, actual revenue was $1.57BBased on 2 analysts’ estimates, the company’s revenue will be $1.67B in the next fiscal year. The high estimate is $1.69B and the low estimate is $1.66B.
